PENK Methylation Test for Detecting Bladder Cancer
Condition(s):Bladder Cancer; Hematuria; BenignLast Updated:February 2, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Bladder Cancer; Hematuria; BenignLast Updated:February 2, 2022Recruiting
Condition(s):Bladder CancerLast Updated:November 21, 2019Completed
Condition(s):Bladder CancerLast Updated:September 29, 2020Not yet recruiting
Condition(s):Bladder CancerLast Updated:January 18, 2022Recruiting
Condition(s):Bladder CancerLast Updated:January 26, 2022Recruiting
Condition(s):Non-Invasive Bladder Urothelial Carcinoma; Non-Invasive Bladder Papillary Urothelial Carcinoma, Low Grade; Non-Invasive Bladder Papillary Urothelial Carcinoma, High GradeLast Updated:February 9, 2021Completed
Condition(s):Bladder CancerLast Updated:January 24, 2022Recruiting
Condition(s):Bladder CancerLast Updated:March 15, 2021Active, not recruiting
Condition(s):Bladder Cancer; SurgeryLast Updated:November 9, 2021Recruiting
Condition(s):Bladder CancerLast Updated:June 4, 2019Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.